Lu Ningning, Yuan Chunwang, Li Jianjun, Sun Bin, Shi Qinsheng, Gao Wenfeng, Ma Liang, Zhang Yonghong
The Center for Hepatology and Oncology Interventional Therapy, Beijing You'an Hospital, Capital Medical University, Beijing, 100069, China.
BMC Gastroenterol. 2025 Jul 1;25(1):489. doi: 10.1186/s12876-025-04092-7.
To investigate the diagnosis and treatment methods for hemothorax resulting from local ablation in patients with primary liver cancer.
A retrospective analysis was conducted on the clinical data of patients who underwent hemothorax after local ablation for liver cancer at the Center for Hepatology and Oncology Interventional Therapy, Beijing You’an Hospital, from January 2022 to December 2023. The study focused on the diagnosis and treatment of postoperative hemothorax, evaluating the effectiveness and safety of these methods.
Seven patients developed postoperative hemothorax after local ablation for liver cancer. Of these, 2 patients achieved hemostasis through symptomatic conservative treatment, while 5 required emergency transcatheter arterial embolization due to active bleeding. All patients recovered and were discharged without severe complications.
Hemothorax is a rare but potentially serious complication following liver cancer ablation. Early diagnosis and timely, effective hemostatic intervention are crucial for a favorable prognosis. Interventional embolization is a safe and effective treatment for active hemothorax post-ablation.
探讨原发性肝癌患者局部消融术后血胸的诊断及治疗方法。
对2022年1月至2023年12月在北京佑安医院肝病与肿瘤介入治疗中心接受肝癌局部消融术后发生血胸的患者临床资料进行回顾性分析。本研究聚焦于术后血胸的诊断与治疗，评估这些方法的有效性和安全性。
7例肝癌局部消融术后患者发生了术后血胸。其中，2例通过对症保守治疗实现止血，而5例因活动性出血需要紧急经导管动脉栓塞术。所有患者均康复出院，无严重并发症。
血胸是肝癌消融术后一种罕见但可能严重的并发症。早期诊断以及及时、有效的止血干预对于良好预后至关重要。介入栓塞术是消融术后活动性血胸的一种安全有效的治疗方法。
Zotero 插件